Report Detail
Global Cancer Drug Therapy Market Insights and Forecast to 2026
- RnM4129728 |
- 12 August, 2020 |
- Global |
- 149 Pages |
- QYResearch |
- Pharma & Healthcare
Cancer Drug Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Drug Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Cancer Drug Therapy market is segmented into
Targeted Therapy
Chemotherapy
Immunotherapy
Segment by Application, the Cancer Drug Therapy market is segmented into
Angiogenesis Inhibitors
mTOR Inhibitors
Monoclonal Antibodies
Cytokine Immunotherapy (IL-2)
Regional and Country-level Analysis
The Cancer Drug Therapy market is analysed and market size information is provided by regions (countries).
The key regions covered in the Cancer Drug Therapy market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Cancer Drug Therapy Market Share Analysis
Cancer Drug Therapy market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Cancer Drug Therapy business, the date to enter into the Cancer Drug Therapy market, Cancer Drug Therapy product introduction, recent developments, etc.
The major vendors covered:
Amgen / Allergan
Argos Therapeutics
AstraZeneca
Aveo Pharmaceuticals
Bayer
Exelixis
Incyte
Merck
Roche
Bristol-Myers Squibb
Eisai
Exelixis
Genentech (Roche)
Novartis
Pfizer
Prometheus Labs
1 Study Coverage
- 1.1 Cancer Drug Therapy Product Introduction
- 1.2 Market Segments
- 1.3 Key Cancer Drug Therapy Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Cancer Drug Therapy Market Size Growth Rate by Type
- 1.4.2 Targeted Therapy
- 1.4.3 Chemotherapy
- 1.4.4 Immunotherapy
- 1.5 Market by Application
- 1.5.1 Global Cancer Drug Therapy Market Size Growth Rate by Application
- 1.5.2 Angiogenesis Inhibitors
- 1.5.3 mTOR Inhibitors
- 1.5.4 Monoclonal Antibodies
- 1.5.5 Cytokine Immunotherapy (IL-2)
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Cancer Drug Therapy Market Size, Estimates and Forecasts
- 2.1.1 Global Cancer Drug Therapy Revenue 2015-2026
- 2.1.2 Global Cancer Drug Therapy Sales 2015-2026
- 2.2 Global Cancer Drug Therapy, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Cancer Drug Therapy Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Cancer Drug Therapy Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Cancer Drug Therapy Competitor Landscape by Players
- 3.1 Cancer Drug Therapy Sales by Manufacturers
- 3.1.1 Cancer Drug Therapy Sales by Manufacturers (2015-2020)
- 3.1.2 Cancer Drug Therapy Sales Market Share by Manufacturers (2015-2020)
- 3.2 Cancer Drug Therapy Revenue by Manufacturers
- 3.2.1 Cancer Drug Therapy Revenue by Manufacturers (2015-2020)
- 3.2.2 Cancer Drug Therapy Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Cancer Drug Therapy Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Cancer Drug Therapy Revenue in 2019
- 3.2.5 Global Cancer Drug Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Cancer Drug Therapy Price by Manufacturers
- 3.4 Cancer Drug Therapy Manufacturing Base Distribution, Product Types
- 3.4.1 Cancer Drug Therapy Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Cancer Drug Therapy Product Type
- 3.4.3 Date of International Manufacturers Enter into Cancer Drug Therapy Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Cancer Drug Therapy Market Size by Type (2015-2020)
- 4.1.1 Global Cancer Drug Therapy Sales by Type (2015-2020)
- 4.1.2 Global Cancer Drug Therapy Revenue by Type (2015-2020)
- 4.1.3 Cancer Drug Therapy Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Cancer Drug Therapy Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Cancer Drug Therapy Sales Forecast by Type (2021-2026)
- 4.2.2 Global Cancer Drug Therapy Revenue Forecast by Type (2021-2026)
- 4.2.3 Cancer Drug Therapy Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Cancer Drug Therapy Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Cancer Drug Therapy Market Size by Application (2015-2020)
- 5.1.1 Global Cancer Drug Therapy Sales by Application (2015-2020)
- 5.1.2 Global Cancer Drug Therapy Revenue by Application (2015-2020)
- 5.1.3 Cancer Drug Therapy Price by Application (2015-2020)
- 5.2 Cancer Drug Therapy Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Cancer Drug Therapy Sales Forecast by Application (2021-2026)
- 5.2.2 Global Cancer Drug Therapy Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Cancer Drug Therapy Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Cancer Drug Therapy by Country
- 6.1.1 North America Cancer Drug Therapy Sales by Country
- 6.1.2 North America Cancer Drug Therapy Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Cancer Drug Therapy Market Facts & Figures by Type
- 6.3 North America Cancer Drug Therapy Market Facts & Figures by Application
7 Europe
- 7.1 Europe Cancer Drug Therapy by Country
- 7.1.1 Europe Cancer Drug Therapy Sales by Country
- 7.1.2 Europe Cancer Drug Therapy Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Cancer Drug Therapy Market Facts & Figures by Type
- 7.3 Europe Cancer Drug Therapy Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Cancer Drug Therapy by Region
- 8.1.1 Asia Pacific Cancer Drug Therapy Sales by Region
- 8.1.2 Asia Pacific Cancer Drug Therapy Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Cancer Drug Therapy Market Facts & Figures by Type
- 8.3 Asia Pacific Cancer Drug Therapy Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Cancer Drug Therapy by Country
- 9.1.1 Latin America Cancer Drug Therapy Sales by Country
- 9.1.2 Latin America Cancer Drug Therapy Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Cancer Drug Therapy Market Facts & Figures by Type
- 9.3 Central & South America Cancer Drug Therapy Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Cancer Drug Therapy by Country
- 10.1.1 Middle East and Africa Cancer Drug Therapy Sales by Country
- 10.1.2 Middle East and Africa Cancer Drug Therapy Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Cancer Drug Therapy Market Facts & Figures by Type
- 10.3 Middle East and Africa Cancer Drug Therapy Market Facts & Figures by Application
11 Company Profiles
- 11.1 Amgen / Allergan
- 11.1.1 Amgen / Allergan Corporation Information
- 11.1.2 Amgen / Allergan Description and Business Overview
- 11.1.3 Amgen / Allergan Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
- 11.1.5 Amgen / Allergan Related Developments
- 11.2 Argos Therapeutics
- 11.2.1 Argos Therapeutics Corporation Information
- 11.2.2 Argos Therapeutics Description and Business Overview
- 11.2.3 Argos Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Argos Therapeutics Cancer Drug Therapy Products Offered
- 11.2.5 Argos Therapeutics Related Developments
- 11.3 AstraZeneca
- 11.3.1 AstraZeneca Corporation Information
- 11.3.2 AstraZeneca Description and Business Overview
- 11.3.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 AstraZeneca Cancer Drug Therapy Products Offered
- 11.3.5 AstraZeneca Related Developments
- 11.4 Aveo Pharmaceuticals
- 11.4.1 Aveo Pharmaceuticals Corporation Information
- 11.4.2 Aveo Pharmaceuticals Description and Business Overview
- 11.4.3 Aveo Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Aveo Pharmaceuticals Cancer Drug Therapy Products Offered
- 11.4.5 Aveo Pharmaceuticals Related Developments
- 11.5 Bayer
- 11.5.1 Bayer Corporation Information
- 11.5.2 Bayer Description and Business Overview
- 11.5.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Bayer Cancer Drug Therapy Products Offered
- 11.5.5 Bayer Related Developments
- 11.6 Exelixis
- 11.6.1 Exelixis Corporation Information
- 11.6.2 Exelixis Description and Business Overview
- 11.6.3 Exelixis Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Exelixis Cancer Drug Therapy Products Offered
- 11.6.5 Exelixis Related Developments
- 11.7 Incyte
- 11.7.1 Incyte Corporation Information
- 11.7.2 Incyte Description and Business Overview
- 11.7.3 Incyte Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Incyte Cancer Drug Therapy Products Offered
- 11.7.5 Incyte Related Developments
- 11.8 Merck
- 11.8.1 Merck Corporation Information
- 11.8.2 Merck Description and Business Overview
- 11.8.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Merck Cancer Drug Therapy Products Offered
- 11.8.5 Merck Related Developments
- 11.9 Roche
- 11.9.1 Roche Corporation Information
- 11.9.2 Roche Description and Business Overview
- 11.9.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Roche Cancer Drug Therapy Products Offered
- 11.9.5 Roche Related Developments
- 11.10 Bristol-Myers Squibb
- 11.10.1 Bristol-Myers Squibb Corporation Information
- 11.10.2 Bristol-Myers Squibb Description and Business Overview
- 11.10.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Bristol-Myers Squibb Cancer Drug Therapy Products Offered
- 11.10.5 Bristol-Myers Squibb Related Developments
- 11.1 Amgen / Allergan
- 11.1.1 Amgen / Allergan Corporation Information
- 11.1.2 Amgen / Allergan Description and Business Overview
- 11.1.3 Amgen / Allergan Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Amgen / Allergan Cancer Drug Therapy Products Offered
- 11.1.5 Amgen / Allergan Related Developments
- 11.12 Exelixis
- 11.12.1 Exelixis Corporation Information
- 11.12.2 Exelixis Description and Business Overview
- 11.12.3 Exelixis Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Exelixis Products Offered
- 11.12.5 Exelixis Related Developments
- 11.13 Genentech (Roche)
- 11.13.1 Genentech (Roche) Corporation Information
- 11.13.2 Genentech (Roche) Description and Business Overview
- 11.13.3 Genentech (Roche) Sales, Revenue and Gross Margin (2015-2020)
- 11.13.4 Genentech (Roche) Products Offered
- 11.13.5 Genentech (Roche) Related Developments
- 11.14 Novartis
- 11.14.1 Novartis Corporation Information
- 11.14.2 Novartis Description and Business Overview
- 11.14.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
- 11.14.4 Novartis Products Offered
- 11.14.5 Novartis Related Developments
- 11.15 Pfizer
- 11.15.1 Pfizer Corporation Information
- 11.15.2 Pfizer Description and Business Overview
- 11.15.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.15.4 Pfizer Products Offered
- 11.15.5 Pfizer Related Developments
- 11.16 Prometheus Labs
- 11.16.1 Prometheus Labs Corporation Information
- 11.16.2 Prometheus Labs Description and Business Overview
- 11.16.3 Prometheus Labs Sales, Revenue and Gross Margin (2015-2020)
- 11.16.4 Prometheus Labs Products Offered
- 11.16.5 Prometheus Labs Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Cancer Drug Therapy Market Estimates and Projections by Region
- 12.1.1 Global Cancer Drug Therapy Sales Forecast by Regions 2021-2026
- 12.1.2 Global Cancer Drug Therapy Revenue Forecast by Regions 2021-2026
- 12.2 North America Cancer Drug Therapy Market Size Forecast (2021-2026)
- 12.2.1 North America: Cancer Drug Therapy Sales Forecast (2021-2026)
- 12.2.2 North America: Cancer Drug Therapy Revenue Forecast (2021-2026)
- 12.2.3 North America: Cancer Drug Therapy Market Size Forecast by Country (2021-2026)
- 12.3 Europe Cancer Drug Therapy Market Size Forecast (2021-2026)
- 12.3.1 Europe: Cancer Drug Therapy Sales Forecast (2021-2026)
- 12.3.2 Europe: Cancer Drug Therapy Revenue Forecast (2021-2026)
- 12.3.3 Europe: Cancer Drug Therapy Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Cancer Drug Therapy Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Cancer Drug Therapy Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Cancer Drug Therapy Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Cancer Drug Therapy Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Cancer Drug Therapy Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Cancer Drug Therapy Sales Forecast (2021-2026)
- 12.5.2 Latin America: Cancer Drug Therapy Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Cancer Drug Therapy Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Cancer Drug Therapy Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Cancer Drug Therapy Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Cancer Drug Therapy Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Cancer Drug Therapy Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Cancer Drug Therapy Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Cancer Drug Therapy Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Cancer Drug Therapy. Industry analysis & Market Report on Cancer Drug Therapy is a syndicated market report, published as Global Cancer Drug Therapy Market Insights and Forecast to 2026. It is complete Research Study and Industry Analysis of Cancer Drug Therapy market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
